Navigation Links
BUSM/BMC researchers awarded $3.5 million grant from the NIDA
Date:7/21/2011

(Boston) - Researchers from the Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) were recently awarded a $3.5 million grant from the National Institute on Drug Abuse (NIDA), to improve upon the "seek, test, treat, and retain" paradigm in Eastern Europe among HIV-infected Russian and Eastern European injection drug users (IDUs) in narcology (addiction) care. The project will be known as LINC, Linking Infectious and Narcology Care.

Russia and Eastern Europe have one of the fastest growing HIV epidemics in the world, with transmission risk primarily from injection drug use. Russia, Ukraine and other countries in the region have implemented routine HIV testing within established addiction treatment systems (narcology hospitals). The narcology system of care, however, works largely independent of other medical care systems and hence has not adopted strategies to link HIV-infected patients to HIV care.

The research will be conducted under the direction of Jeffrey H. Samet, MD, a professor of medicine and community health sciences at BUSM and BU School of Public Health and chief of the Section of General Internal Medicine at BMC. Samet was recently selected as a NIDA International Program 2011 Awards of Excellence winner.

According to the researchers, the narcology system of care works largely independent of other medical care systems and hence has not adopted strategies to link HIV-infected patients to HIV care. As in the United States in the 1990s, delayed or non-receipt of HIV medical care, particularly among IDUs, is common in Russia. According to Samet, the principal investigator of the study, this is a missed opportunity since up to 45 percent of Russian IDUs in narcology treatment are HIV infected, yet as few as 20 percent of those infected are in care.

"The objective of this study is to implement and assess a behavioral and structural intervention in Russia designed to support and motivate HIV-infected heroin dependent narcology patients to engage in HIV medical care and ultimately improve their HIV outcomes," said Samet.

LINC is a clinical model designed to coordinate narcology and HIV systems of care using an intervention inclusive of staff from both systems and composed of elements shown to facilitate engagement in medical care: HIV case management and nurse home visits. The central hypothesis is that an intervention that involves coordination between the narcology and HIV systems will lead to increased engagement in HIV medical care. "Coordination will involve HIV case management delivered by a peer to help motivate and reduce barriers to HIV care engagement and enhanced outpatient narcology treatment delivered by an addiction nurse with communication between these providers," added Samet.

The project will be undertaken by an international research team experienced in addressing HIV, substance use, and clinical interventions in Russia.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. U of M researchers improve method to create induced pluripotent stem cells
2. URMC researchers exploring keys to melanoma progression
3. University of Maryland researchers discover possible drug targets for common non-Hodgkins lymphoma
4. RI Hospital researchers find common test may be unnecessary for bariatric surgery candidates
5. Over half of Alzheimers cases may be preventable, say researchers
6. Penn researchers find neural signature of mental time travel
7. Researchers identify how a gene linked to both Alzheimers disease and type 2 diabetes works
8. NYU researchers develop compound to block signaling of cancer-causing protein
9. Mayo researchers: Genetic mutation linked to Parkinsons disease
10. Researchers Closer to Developing Universal Meningitis B Vaccine
11. Novel Virus Jumped From Monkeys to Humans, Researchers Find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... California Senate Bill (SB) 863, signed into law in 2012, ... and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , a ... study, medical payments per claim in California decreased 4 percent in 2013 and then ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne ... offices headquartered in Hamilton County, is embarking on a charity drive with the ... finding new homes for orphaned or neglected senior dogs in the Cincinnati region, ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and financial consulting services to residential and commercial clients in the northern Alabama ... support for Nobis Works. , Since 1977, Nobis Works has built a network ...
(Date:12/7/2016)... ... December 07, 2016 , ... Kenall Manufacturing, a leader in sealed healthcare lighting ... MPCNGX is a multi-function, sealed, LED luminaire that meets the needs of everyone in ... it’s needed. , A 2’ x 4’ model features four modes: reading, ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... (“Presence”) for a purchase price of approximately $17.4 million (net of the ... revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is a ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- A Small Business Innovative Research (SBIR) grant has ... to Phoenix -based NeuroEM Therapeutics, Inc. ... will seek to determine an optimal set of treatment ... to treat Alzheimer,s Disease. The grant will also investigate ... other neurologic disorders such as Parkinson,s Disease and PTSD. ...
(Date:12/8/2016)... 2016 According to the research report, ... is expected to be worth US$9.7 bn by the ... Between the forecast years of 2016 and 2024, the global ... The leading players operating in the global diabetes injection pens ... plc., Biocon Ltd., and Sanofi S.A. Transparency Market Research reports ...
(Date:12/8/2016)... 8, 2016 According to ... by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), ... Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global ... has witnessed healthy growth during the last decade, ... of 4.3% between 2016 and 2021 to reach ...
Breaking Medicine Technology: